Exagen (XGN) Capital Expenditures (2018 - 2026)
Exagen (XGN) reported Capital Expenditures of $228000.0 for Q1 2026, up 101.77% on a YoY basis from $113000.0 in Q1 2025, and down 63.46% quarter-over-quarter from $624000.0 in Q4 2025.
Exagen (XGN) Capital Expenditures (2018 - 2026) Analysis & Trends
Exagen has reported Capital Expenditures for 9 years, with the latest figure at $228000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 101.77% year-over-year to $228000.0; the trailing twelve-month figure through Mar 2026 stood at $756000.0 (up 39.48% YoY), and the FY2025 full-year result was $641000.0, up 24.47% from the prior year.
- Capital Expenditures for Q1 2026 stood at $228000.0, down from $624000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.9 million in Q2 2022, with the low at -$656000.0 in Q4 2023.
- Historically, Capital Expenditures has averaged $339294.1 across 5 years, with a median of $209000.0 in 2025.
- Annual changes were most pronounced in 2024 — Capital Expenditures surged 7250.0% — and 2025, when it plunged 307.48%.
- Exagen's Capital Expenditures stood at $406000.0 in 2022, then plunged by 261.58% to -$656000.0 in 2023, then surged by 122.26% to $146000.0 in 2024, then jumped by 327.4% to $624000.0 in 2025, then tumbled by 63.46% to $228000.0 in 2026.
- The last three Capital Expenditures figures came in at $228000.0 (Q1 2026), $624000.0 (Q4 2025), and -$305000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 39.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 376.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 237.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 8.27 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 76.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 22.14 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 127.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 38.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 17.41 Mn |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | 228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228,000.00 |
| Mar 31, 2026 | 228,000.00 |
| Dec 31, 2025 | 624,000.00 |
| Dec 31, 2025 | 624,000.00 |
| Sep 30, 2025 | -305,000.00 |
| Sep 30, 2025 | -305,000.00 |
| Jun 30, 2025 | 209,000.00 |
| Jun 30, 2025 | 209,000.00 |
| Mar 31, 2025 | 113,000.00 |
| Mar 31, 2025 | 113,000.00 |
| Dec 31, 2024 | 146,000.00 |
| Dec 31, 2024 | 146,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | -656,000.00 |
| Dec 31, 2023 | -656,000.00 |